Adam Zaricki is Chief Strategy Officer of the not-for-profit Schroeder Ambulatory Centre, a new 200,000-square-foot, multi-specialty Integrated Community Health Services Centre (ICHSC) located in Richmond Hill, Ontario. The Centre opened to patients in October 2025 and is focused on publicly insured outpatient surgeries and a variety of clinical and diagnostic imaging services. Since the project start in 2021, Adam led all business and clinical program planning, collaborated on the architectural design, led licensing efforts, and supported operational launch of the facility.
In concurrent work with the Schroeder Foundation, Adam supported philanthropic healthcare projects, including initiating long-term clinical research in orthobiologic therapies for osteoarthritis at UHN Toronto Western Hospital. Previously, he served as Vice President of Corporate Strategy at U.S.-based NantHealth, where he led the launch of GPSCancer, one of the first whole genome/exome sequencing tests for cancer therapy decision support, and oversaw product strategy for cell therapy manufacturing devices. Earlier, he was founding CEO of Peake Healthcare Innovations, a joint venture of Johns Hopkins Medicine and L3Harris Technologies that built one of the first secure cloud-based services for medical image management. His 20-year career at L3Harris began in aerospace engineering and program leadership across numerous complex technology development projects, including leading a 100+ person team that delivered the world’s largest deployable commercial satellite antenna.
Adam holds master’s and bachelor’s degrees in engineering from the University of Florida and lives in Melbourne Beach, Florida.